Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

224 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PARP Inhibitors as Monotherapy in Daily Practice for Advanced Prostate Cancers.
Teyssonneau D, Thiery-Vuillemin A, Dariane C, Barret E, Beauval JB, Brureau L, Créhange G, Fiard G, Fromont G, Gauthé M, Ruffion A, Renard-Penna R, Mathieu R, Sargos P, Rouprêt M, Ploussard G, Roubaud G, On Behalf Of The Cc-Afu Cancerology Committee Of The Association Française d'Urologie. Teyssonneau D, et al. Among authors: crehange g. J Clin Med. 2022 Mar 21;11(6):1734. doi: 10.3390/jcm11061734. J Clin Med. 2022. PMID: 35330059 Free PMC article. Review.
[Hypofractionnated radiotherapy for elderly patients with prostate cancer].
Sargos P, Créhange G, Hennequin C, Latorzeff I, de Crevoisier R, Roubaud G, Supiot S. Sargos P, et al. Among authors: crehange g. Cancer Radiother. 2018 Oct;22(6-7):631-634. doi: 10.1016/j.canrad.2018.07.124. Epub 2018 Aug 23. Cancer Radiother. 2018. PMID: 30145092 Review. French.
Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial.
Carrie C, Magné N, Burban-Provost P, Sargos P, Latorzeff I, Lagrange JL, Supiot S, Belkacemi Y, Peiffert D, Allouache N, Dubray BM, Servagi-Vernat S, Suchaud JP, Crehange G, Guerif S, Brihoum M, Barbier N, Graff-Cailleaud P, Ruffion A, Dussart S, Ferlay C, Chabaud S. Carrie C, et al. Among authors: crehange g. Lancet Oncol. 2019 Dec;20(12):1740-1749. doi: 10.1016/S1470-2045(19)30486-3. Epub 2019 Oct 16. Lancet Oncol. 2019. PMID: 31629656 Clinical Trial.
[Indications and outlooks of radiohormonal therapy of high-risk prostate cancers].
Latorzeff I, Sargos P, Créhange G, Belkacémi Y, Azria D, Hasbini A, Dubergé T, Toledano A, Graff-Cailleaud P, Chapet O, Hennequin C, de Crevoisier R, Supiot S, Pasquier D. Latorzeff I, et al. Among authors: crehange g. Cancer Radiother. 2020 Apr;24(2):143-152. doi: 10.1016/j.canrad.2019.06.018. Epub 2020 Feb 11. Cancer Radiother. 2020. PMID: 32057646 Review. French.
[French ccAFU guidelines - update 2020-2022: prostate cancer].
Rozet F, Mongiat-Artus P, Hennequin C, Beauval JB, Beuzeboc P, Cormier L, Fromont-Hankard G, Mathieu R, Ploussard G, Renard-Penna R, Brenot-Rossi I, Bruyere F, Cochet A, Crehange G, Cussenot O, Lebret T, Rebillard X, Soulié M, Brureau L, Méjean A. Rozet F, et al. Among authors: crehange g. Prog Urol. 2020 Nov;30(12S):S136-S251. doi: 10.1016/S1166-7087(20)30752-1. Prog Urol. 2020. PMID: 33349424 French.
[A review of adaptive radiotherapy for bladder cancer].
Cabaillé M, Khalifa J, Tessier AM, Belhomme S, Créhange G, Sargos P. Cabaillé M, et al. Among authors: crehange g. Cancer Radiother. 2021 May;25(3):271-278. doi: 10.1016/j.canrad.2020.08.046. Epub 2021 Jan 2. Cancer Radiother. 2021. PMID: 33402293 Review. French.
Focal Brachytherapy for Localized Prostate Cancer: Midterm Outcomes.
Ta MH, Nunes-Silva I, Barret E, Renard-Penna R, Rozet F, Mombet A, Cathala N, Sanchez-Salas R, Créhange G, Cathelineau X, Cosset JM. Ta MH, et al. Among authors: crehange g. Pract Radiat Oncol. 2021 Sep-Oct;11(5):e477-e485. doi: 10.1016/j.prro.2020.12.005. Epub 2021 Jan 7. Pract Radiat Oncol. 2021. PMID: 33422681
224 results